An open-label, randomised, parallel clinical research evaluating the safety and efficacy of methotrexate and apremilast in patients with moderate to severe palm plantar psoriasis. Int. Res. J. Pharm. 2027;15(7):8-18. Accessed October 30, 2026. https://irjponline.org/index.php/irjp/article/view/3131